Abstract:Cytochrome P450 3A4 (CYP3A4), a key enzyme, is pivotal in metabolizing approximately half of the drugs used clinically. The genetic polymorphism of the CYP3A4 gene significantly influences individual variations in drug metabolism, potentially leading to severe adverse drug reactions (ADRs). In this study, we conducted a genetic analysis on CYP3A4 gene in 1163 Chinese Han individuals to identify the genetic variations that might affect their drug metabolism capabilities. For this purpose, a multiplex polymerase chain reaction (PCR) amplicon sequencing technique was developed, enabling us to perform the genotyping of CYP3A4 gene efficiently and economically on a large scale. As a result, a total of 14 CYP3A4 allelic variants were identified, comprising six previously reported alleles and eight new nonsynonymous variants that were nominated as new allelic variants *39–*46 by the PharmVar Association. Further, functional assessments of these novel CYP3A4 variants were undertaken by coexpressing them with cytochromes P450 oxidoreductase (CYPOR) in Saccharomyces cerevisiae microsomes. Immunoblot analysis indicated that with the exception of CYP3A4.40 and CYP3A4.45, the protein expression levels of most new variants were similar to that of the wild-type CYP3A4.1 in yeast cells. To evaluate their catalytic activities, midazolam was used as a probe drug. The results showed that variant CYP3A4.45 had almost no catalytic activity, whereas the other variants exhibited significantly reduced drug metabolism abilities. This suggests that the majority of the CYP3A4 variants identified in the Chinese population possess markedly altered capacities for drug metabolism. SIGNIFICANCE STATEMENT In this study, we established a multiplex polymerase chain reaction (PCR) amplicon sequencing method and detected the maximum number of new CYP3A4 variants in a single ethnic population. Additionally, we performed the functional characterizations of these eight novel CYP3A4 allele variants in vitro. This study not only contributes to the understanding of CYP3A4 genetic polymorphism in the Chinese Han population but also holds substantial reference value for their potential clinical applications in personalized medicine.

Variants of CYP27B1 Are Associated with Both Multiple Sclerosis and Neuromyelitis Optica Patients in Han Chinese Population

Variants in the Promoter Region of CYP7A1 Are Associated with Neuromyelitis Optica but Not with Multiple Sclerosis in the Han Chinese Population.

Variants of Interleukin-7/Interleukin-7 Receptor Alpha Are Associated with Both Neuromyelitis Optica and Multiple Sclerosis among Chinese Han Population in Southeastern China.

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

No Association Between Identified Multiple Sclerosis Non-Mhc Risk Loci and Neuromyelitis Optica

Variants of Interferon Regulatory Factor 5 Are Associated with Neither Neuromyelitis Optica nor Multiple Sclerosis in the Southeastern Han Chinese Population.

Variants of Autophagy-Related Gene 5 Are Associated with Neuromyelitis Optica in the Southern Han Chinese Population

CD226 Gly307Ser Association with Neuromyelitis Optica in Southern Han Chinese.

IL2RA Allele Increases Risk of Neuromyelitis Optica in Southern Han Chinese.

Functional Variant Rs3135500 in NOD2 Increases the Risk of Multiple System Atrophy in a Chinese Population

SNP Rs11931074 of Thesncagene May Not Be Associated with Multiple System Atrophy in Chinese Population

Association of CD58 Gene Polymorphisms with NMO Spectrum Disorders in a Han Chinese Population

Myelin oligodendrocyte glycoprotein-associated disease is associated with <i>BANK1</i>, <i>RNASET2</i> and <i>TNIP1</i> polymorphisms

Myelin oligodendrocyte glycoprotein-associated disease is associated with BANK1, RNASET2 and TNIP1 polymorphisms

Genetic Variants Regulate NR1H3 Expression and Contribute to Multiple Sclerosis Risk.

Common Genetic Variants in PRRC2A Are Associated with Both Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Han Chinese Population

Determining the Effect of the HNMT , STK39 , and NMD3 Polymorphisms on the Incidence of Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Multiple System Atrophy in Chinese Populations

Associations of Common Variants in Methionine Metabolism Pathway Genes with Plasma Homocysteine and the Risk of Type 2 Diabetes in Han Chinese

SNCA variants rs2736990 and rs356220 as risk factors for Parkinson's disease but not for amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population.

Variant of EOMES Associated with Increasing Risk in Chinese Patients with Relapsing-remitting Multiple Sclerosis

Association of TNF-α Rs1799964 and IL-1β Rs16944 Polymorphisms with Multiple System Atrophy in Chinese Han Population.